Skip to main content

18 May 2026

Last updated: Monday 18 May 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

The risks of therapeutic genome editing

Sunday 25 June 2017

Interviewee/Contributor

Houria Bachtarzi and Tim Farries

Organisation

ERA Consulting (UK) Ltd

Organisations

Innovation and International Relationship
US National Cancer Institute
Truffle Capital
Nextech Invest Ltd
LifeSci Advisors
Hutchison China MediTech
GE Healthcare
NDA Regulatory Science Ltd
Strategus
Enterome SA

Interviewees and Contributers

Nick Bassil
Gerben Moolhuizen and Kees Melief
Anthony Sedgwick
Nick Seay
Marjanne Prins
Jack Barbut
Julian Hitchcock
Hugh Davies
Alan Aubrey
John Beeler and Andrew Newland

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Curacell names two board members

Monday 18 May 2026

Seaport Therapeutics names biotech leader to board

Monday 18 May 2026

New CMO at Immunic

Monday 18 May 2026

Reacta Healthcare appoints allergy expert to advisory board

Monday 18 May 2026

Qlaris Bio appoints CEO

Monday 18 May 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form